Given the potential significance of the key ferroptosis regulator SLC7A11 in LIHC progression and treatment, we performed a pan-cancer analysis of SLC7A11 based on TCGA and GTEx databases to examine the similarities and differences in prognoses and IC responsiveness across 33 tumor types. This evidence concerns the gene SLC7A11 and cancer.